Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Esophagus”

467 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 467 results

Not applicableLooking for participantsNCT06440174
What this trial is testing

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

Who this might be right for
Oesophageal Cancer
University Hospital Southampton NHS Foundation Trust 160
Not applicableEnrolling By InvitationNCT06160557
What this trial is testing

A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophagus CancerRadiotherapyEndoscopic Mucosal Resection
Xiaomeng Zheng 40
Large-scale testing (Phase 3)Study completedNCT00270166
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Who this might be right for
AnemiaMultiple MyelomaLymphoma+6 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Early research (Phase 1)Study completedNCT05023928
What this trial is testing

Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer

Who this might be right for
CarcinomaEsophagus Cancer
Sichuan University 25
Early research (Phase 1)UnknownNCT02970539
What this trial is testing

Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers

Who this might be right for
Gastric CancerEsophageal CancerGastro-esophageal Cancer
Athenex, Inc. 36
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT01830270
What this trial is testing

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

Who this might be right for
Stomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon 30
Very early researchStudy completedNCT02744729
What this trial is testing

99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients

Who this might be right for
Esophageal Cancer
First Affiliated Hospital of Fujian Medical University 29
Testing effectiveness (Phase 2)Study completedNCT02879227
What this trial is testing

Radiochemotherapy in Elderly Patients With Oesophagus Cancer

Who this might be right for
Esophagus Cancer
Centre Hospitalier Universitaire de Besancon 23
Early research (Phase 1)Study completedNCT01938612
What this trial is testing

A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumors
AstraZeneca 269
Testing effectiveness (Phase 2)Study completedNCT01443065
What this trial is testing

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
UNICANCER 162
Early research (Phase 1)Study completedNCT03205501
What this trial is testing

Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions

Who this might be right for
Barrett EsophagusEsophageal CancerDysplasia in Barrett Esophagus
University Medical Center Groningen 15
Early research (Phase 1)Study completedNCT02642809
What this trial is testing

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Who this might be right for
Esophageal CancerCancer of the Esophagus
Washington University School of Medicine 16
Testing effectiveness (Phase 2)Ended earlyNCT02054104
What this trial is testing

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Who this might be right for
Thoracic SarcomasThorasic CancersCancers of Non-thoracic Origin With Metastases to the Lungs or Pleura+2 more
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Not applicableStudy completedNCT02382237
What this trial is testing

Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition

Who this might be right for
Head and Neck CancerOesophageal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850
What this trial is testing

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Not applicableNot Yet RecruitingNCT06662513
What this trial is testing

Post Oesophagectomy Outcomes in a Single Regional Centre in Australia

Who this might be right for
Oesophageal Cancer
Launceston General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03653052
What this trial is testing

Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab

Who this might be right for
Oesophageal Cancer
Simon C Pacey, MD 18
Testing effectiveness (Phase 2)Study completedNCT00201747
What this trial is testing

Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

Who this might be right for
Esophageal CancerEsophagus CancerCancer of Stomach+1 more
Ohio State University Comprehensive Cancer Center 80
Load More Results